Terns Pharmaceuticals (NASDAQ:TERN) Price Target Raised to $7.50
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) had its price objective increased by stock analysts at HC Wainwright from $5.50 to $7.50 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. HC Wainwright’s price target points to a potential upside of 9.17% from the stock’s […]
More Stories
Pallas Capital Advisors LLC Has $2.66 Million Stake in Applied Materials, Inc. (NASDAQ:AMAT)
Pallas Capital Advisors LLC reduced its position in Applied Materials, Inc. (NASDAQ:AMAT – Free Report) by 72.9% in the 4th...
Pallas Capital Advisors LLC Sells 2,156 Shares of Ventas, Inc. (NYSE:VTR)
Pallas Capital Advisors LLC lowered its position in Ventas, Inc. (NYSE:VTR – Free Report) by 1.6% during the fourth quarter,...
Burns J W & Co. Inc. NY Sells 196 Shares of CME Group Inc. (NASDAQ:CME)
Burns J W & Co. Inc. NY trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report)...
Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) Position Reduced by Noble Family Wealth LLC
Noble Family Wealth LLC reduced its position in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report) by...
Pallas Capital Advisors LLC Purchases 2,471 Shares of JPMorgan ActiveBuilders Emerging Markets Equity ETF (BATS:JEMA)
Pallas Capital Advisors LLC boosted its holdings in shares of JPMorgan ActiveBuilders Emerging Markets Equity ETF (BATS:JEMA – Free Report)...
Aehr Test Systems (NASDAQ:AEHR) Announces Earnings Results, Misses Expectations By $0.02 EPS
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) issued its earnings results on Monday. The semiconductor company reported ($0.01) EPS...